TCG Crossover Management as of Dec. 31, 2021
Portfolio Holdings for TCG Crossover Management
TCG Crossover Management holds 15 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iveric Bio Common Stock | 13.6 | $29M | 1.7M | 16.72 | |
| Viridian Therapeutics Common Stock (VRDN) | 12.2 | $26M | 1.3M | 19.77 | |
| Cogent Biosciences Common Stock (COGT) | 11.0 | $24M | 2.8M | 8.58 | |
| Cymabay Therapeutics Common Stock | 9.3 | $20M | 5.9M | 3.38 | |
| Alpine Immune Sciences Common Stock | 7.6 | $16M | 1.2M | 13.85 | |
| Aclaris Therapeuitics Common Stock (ACRS) | 7.4 | $16M | 1.1M | 14.54 | |
| Chinook Therapeutics Common Stock | 6.7 | $14M | 882k | 16.31 | |
| Tyra Biosciences Common Stock (TYRA) | 5.6 | $12M | 851k | 14.07 | |
| Entrada Therapeutics Common Stock (TRDA) | 5.3 | $11M | 664k | 17.12 | |
| Aerovate Therapeutics Common Stock (AVTE) | 4.7 | $10M | 853k | 11.79 | |
| Magenta Therapeutics Common Stock | 4.6 | $9.8M | 2.2M | 4.43 | |
| Akouos Common Stock | 4.2 | $8.9M | 1.0M | 8.50 | |
| Merus Common Stock (MRUS) | 3.4 | $7.2M | 225k | 31.80 | |
| Zai Lab Common Stock (ZLAB) | 2.8 | $6.0M | 95k | 62.85 | |
| Elevation Oncology Common Stock (ELEV) | 1.6 | $3.3M | 555k | 6.02 |
